Plaque angiogenesis and intraplaque hemorrhage in atherosclerosis

European Journal of Pharmacology

Volumn 816, Issue , 2017, Pages 107-115

  Parma, Laura ^a   Baganha, Fabiana ^a   Quax, Paul H A ^a   de Vries, Margreet R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; Atherosclerosis; Intraplaque hemorrhage; Plaque neovessels; VEGF

Indexed keywords

3 DEAZAADENOSINE; ANGIOPOIETIN 2; BEVACIZUMAB; ENDOSTATIN; RECOMBINANT ENDOSTATIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLEEDING; CELL GROWTH; CELL METABOLISM; DRUG EFFECT; DRUG TARGETING; ENDOTHELIUM CELL; ERYTHROCYTE; HEMODYNAMICS; HUMAN; HYPOXIA; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; COMPLICATION; DIAGNOSTIC IMAGING; MOLECULAR IMAGING; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY;

ANIMALS; HEMORRHAGE; HUMANS; MOLECULAR IMAGING; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC;

EID: 85018677323     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2017.04.028     Document Type: Article

References (120)

1. Aarup, A., Pedersen, T.X., Junker, N., Christoffersen, C., Bartels, E.D., Madsen, M., Nielsen, C.H., Nielsen, L.B., Hypoxia-inducible factor-1alpha expression in macrophages promotes development of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 36:9 (2016), 1782–1790.
2. Alie, N., Eldib, M., Fayad, Z.A., Mani, V., Inflammation, atherosclerosis, and coronary artery disease: PET/CT for the evaluation of atherosclerosis and inflammation. Clin. Med. Insights Cardiol. 8:Suppl 3 (2014), S13–S21.
3. Ando, J., Yamamoto, K., Flow detection and calcium signalling in vascular endothelial cells. Cardiovasc. Res. 99:2 (2013), 260–268.
4. Bendall, J.K., Douglas, G., McNeill, E., Channon, K.M., Crabtree, M.J., Tetrahydrobiopterin in cardiovascular health and disease. Antioxid. Redox Signal. 20:18 (2014), 3040–3077.
5. Bogdanovich, S., Kim, Y., Mizutani, T., Yasuma, R., Tudisco, L., Cicatiello, V., Bastos-Carvalho, A., Kerur, N., Hirano, Y., Baffi, J.Z., Tarallo, V., Li, S., Yasuma, T., Arpitha, P., Fowler, B.J., Wright, C.B., Apicella, I., Greco, A., Brunetti, A., Ruvo, M., Sandomenico, A., Nozaki, M., Ijima, R., Kaneko, H., Ogura, Y., Terasaki, H., Ambati, B.K., Leusen, J.H., Langdon, W.Y., Clark, M.R., Armour, K.L., Bruhns, P., Verbeek, J.S., Gelfand, B.D., De Falco, S., Ambati, J., Human IgG1 antibodies suppress angiogenesis in a target-independent manner. Signal Transduct. Target Ther., 1, 2016.
6. Bongrazio, M., Da Silva-Azevedo, L., Bergmann, E.C., Baum, O., Hinz, B., Pries, A.R., Zakrzewicz, A., Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo. Int J. Immunopathol. Pharmacol. 19:1 (2006), 35–48.
7. Bourantas, C.V., Garcia-Garcia, H.M., Torii, R., Zhang, Y.J., Westwood, M., Crake, T., Serruys, P.W., Vulnerable plaque detection: an unrealistic quest or a feasible objective with a clinical value?. Heart 102:8 (2016), 581–589.
8. Bourantas, C.V., Jaffer, F.A., Gijsen, F.J., van Soest, G., Madden, S.P., Courtney, B.K., Fard, A.M., Tenekecioglu, E., Zeng, Y., van der Steen, A.F., Emelianov, S., Muller, J., Stone, P.H., Marcu, L., Tearney, G.J., Serruys, P.W., Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology. Eur. Heart J., 2016.
9. Butoi, E., Gan, A.M., Tucureanu, M.M., Stan, D., Macarie, R.D., Constantinescu, C., Calin, M., Simionescu, M., Manduteanu, I., Cross-talk between macrophages and smooth muscle cells impairs collagen and metalloprotease synthesis and promotes angiogenesis. Biochim. Biophys. Acta- Mol. Cell Res. 1863:7, Part A (2016), 1568–1578.
10. Calcagno, C., Mulder, W.J.M., Nahrendorf, M., Fayad, Z.A., Systems biology and noninvasive imaging of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 36:2 (2016), e1–e8.
11. Cantelmo, A.R., Brajic, A., Carmeliet, P., Endothelial metabolism driving angiogenesis emerging concepts and principles. Cancer J. 21:4 (2015), 244–249.
12. Carmeliet, P., Jain, R.K., Molecular mechanisms and clinical applications of angiogenesis. Nature 473:7347 (2011), 298–307.
13. Chaabane, C., Coen, M., Bochaton-Piallat, M.L., Smooth muscle cell phenotypic switch: implications for foam cell formation. Curr. Opin. Lipidol. 25:5 (2014), 374–379.
14. Coulon, C., Georgiadou, M., Roncal, C., De Bock, K., Langenberg, T., Carmeliet, P., From vessel sprouting to normalization: role of the prolyl hydroxylase domain protein/hypoxia-inducible factor oxygen-sensing machinery. Arterioscler. Thromb. Vasc. Biol. 30:12 (2010), 2331–2336.
15. Crucet, M., Wust, S.J., Spielmann, P., Luscher, T.F., Wenger, R.H., Matter, C.M., Hypoxia enhances lipid uptake in macrophages: role of the scavenger receptors Lox1, SRA, and CD36. Atherosclerosis 229:1 (2013), 110–117.
16. Cruys, B., Wong, B.W., Kuchnio, A., Verdegem, D., Cantelmo, A.R., Conradi, L.-C., Vandekeere, S., Bouché, A., Cornelissen, I., Vinckier, S., Merks, R.M.H., Dejana, E., Gerhardt, H., Dewerchin, M., Bentley, K., Carmeliet, P., Glycolytic regulation of cell rearrangement in angiogenesis. Nat. Commun., 7, 2016, 12240.
17. Cummins, E.P., Berra, E., Comerford, K.M., Ginouves, A., Fitzgerald, K.T., Seeballuck, F., Godson, C., Nielsen, J.E., Moynagh, P., Pouyssegur, J., Taylor, C.T., Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc. Natl. Acad. Sci. USA 103:48 (2006), 18154–18159.
18. D'Ignazio, L., Bandarra, D., Rocha, S., NF-kappaB and HIF crosstalk in immune responses. Febs J. 283:3 (2016), 413–424.
19. De Smet, F., Segura, I., De Bock, K., Hohensinner, P.J., Carmeliet, P., Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way. Arterioscler. Thromb. Vasc. Biol. 29:5 (2009), 639–649.
20. de Vries, M.R., Niessen, H.W., Lowik, C.W., Hamming, J.F., Jukema, J.W., Quax, P.H., Plaque rupture complications in murine atherosclerotic vein grafts can be prevented by TIMP-1 overexpression. PLoS One, 7(10), 2012, e47134.
21. de Vries, M.R., Quax, P.H., Plaque angiogenesis and its relation to inflammation and atherosclerotic plaque destabilization. Curr. Opin. Lipidol. 27:5 (2016), 499–506.
22. de Vries, M.R., Simons, K.H., Jukema, J.W., Braun, J., Quax, P.H., Vein graft failure: from pathophysiology to clinical outcomes. Nat. Rev. Cardiol. 13:8 (2016), 451–470.
23. De Bock, K., Georgiadou, M., Carmeliet, P., Role of endothelial cell metabolism in vessel sprouting. Cell Metab. 18:5 (2013), 634–647.
24. De Bock, K., Georgiadou, M., Schoors, S., Kuchnio, A., Wong, Brian W., Cantelmo, Anna R., Quaegebeur, A., Ghesquière, B., Cauwenberghs, S., Eelen, G., Phng, L.-K., Betz, I., Tembuyser, B., Brepoels, K., Welti, J., Geudens, I., Segura, I., Cruys, B., Bifari, F., Decimo, I., Blanco, R., Wyns, S., Vangindertael, J., Rocha, S., Collins, Russel T., Munck, S., Daelemans, D., Imamura, H., Devlieger, R., Rider, M., Van Veldhoven, Paul P., Schuit, F., Bartrons, R., Hofkens, J., Fraisl, P., Telang, S., DeBerardinis, Ralph J., Schoonjans, L., Vinckier, S., Chesney, J., Gerhardt, H., Dewerchin, M., Carmeliet, P., Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 154:3 (2013), 651–663.
25. Diebold, I., Petry, A., Sabrane, K., Djordjevic, T., Hess, J., Gorlach, A., The HIF1 target gene NOX2 promotes angiogenesis through urotensin-II. J. Cell Sci. 125:Pt 4 (2012), 956–964.
26. Dorweiler, B., Torzewski, M., Dahm, M., Kirkpatrick, C.J., Lackner, K.J., Vahl, C.F., Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima. Thromb. Haemost. 99:2 (2008), 373–381.
27. Drummond, G.R., Sobey, C.G., Endothelial NADPH oxidases: which NOX to target in vascular disease?. Trends Endocrinol. Metab. 25:9 (2014), 452–463.
28. Eelen, G., Cruys, B., Welti, J., De Bock, K., Carmeliet, P., Control of vessel sprouting by genetic and metabolic determinants. Trends Endocrinol. Metab. 24:12 (2013), 589–596.
29. Ehara, S., Kobayashi, Y., Yoshiyama, M., Shimada, K., Shimada, Y., Fukuda, D., Nakamura, Y., Yamashita, H., Yamagishi, H., Takeuchi, K., Naruko, T., Haze, K., Becker, A.E., Yoshikawa, J., Ueda, M., Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation 110:22 (2004), 3424–3429.
30. Eriksson, E.E., Intravital microscopy on atherosclerosis in apolipoprotein e-deficient mice establishes microvessels as major entry pathways for leukocytes to advanced lesions. Circulation 124:19 (2011), 2129–2138.
31. Fantin, A., Vieira, J.M., Gestri, G., Denti, L., Schwarz, Q., Prykhozhij, S., Peri, F., Wilson, S.W., Ruhrberg, C., Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 116:5 (2010), 829–840.
32. Folco, E.J., Sukhova, G.K., Quillard, T., Libby, P., Moderate hypoxia potentiates interleukin-1beta production in activated human macrophages. Circ. Res. 115:10 (2014), 875–883.
33. Fong, G.H., Potential contributions of intimal and plaque hypoxia to atherosclerosis. Curr. Atheroscler. Rep., 17(6), 2015, 510.
34. Giannarelli, C., Ibanez, B., Cimmino, G., Garcia Ruiz, J.M., Faita, F., Bianchini, E., Zafar, M.U., Fuster, V., Garcia, M.J., Badimon, J.J., Contrast-enhanced ultrasound imaging detects intraplaque neovascularization in an experimental model of atherosclerosis. JACC Cardiovasc. Imaging 3:12 (2010), 1256–1264.
35. Giannoglou, G.D., Koskinas, K.C., Tziakas, D.N., Ziakas, A.G., Antoniadis, A.P., Tentes I.K., Parcharidis, G.K., Total cholesterol content of erythrocyte membranes and coronary atherosclerosis: an intravascular ultrasound pilot study. Angiology, 60(6), 2009 Dec–2010 Jan, 676–82.
36. Goel, S., Wong, A.H., Jain, R.K., Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease. Cold Spring Harb. Perspect. Med., 2(3), 2012, a006486.
37. Goetz, J.G., Steed, E., Ferreira, R.R., Roth, S., Ramspacher, C., Boselli, F., Charvin, G., Liebling, M., Wyart, C., Schwab, Y., Vermot, J., Endothelial cilia mediate low flow sensing during zebrafish vascular development. Cell Rep. 6:5 (2014), 799–808.
38. Goncalves, I., den Ruijter, H., Nahrendorf, M., Pasterkamp, G., Detecting the vulnerable plaque in patients. J. Intern. Med. 278:5 (2015), 520–530.
39. Haasdijk, R.A., Den Dekker, W.K., Cheng, C., Tempel, D., Szulcek, R., Bos, F.L., Hermkens, D.M., Chrifi, I., Brandt, M.M., Van Dijk, C., Xu, Y.J., Van De Kamp, E.H., Blonden, L.A., Bezu, J. Van, Sluimer, J.C., Biessen, E.A., Van Nieuw Amerongen, G.P., Duckers, H.J., THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE-/- mice. Cardiovasc. Res. 110:1 (2016), 129–139.
40. Hansson, G.K., Libby, P., Tabas, I., Inflammation and plaque vulnerability. J. Intern. Med. 278:5 (2015), 483–493.
41. Hellings, W.E., Peeters, W., Moll, F.L., Piers, S.R., van Setten, J., Van der Spek, P.J., de Vries, J.P., Seldenrijk, K.A., De Bruin, P.C., Vink, A., Velema, E., de Kleijn, D.P., Pasterkamp, G., Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation 121:17 (2010), 1941–1950.
42. Herbert, S.P., Stainier, D.Y., Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat. Rev. Mol. Cell Biol. 12:9 (2011), 551–564.
43. Ho, T.K., Abraham, D.J., Black, C.M., Baker, D.M., Hypoxia-inducible factor 1 in lower limb ischemia. Vascular 14:6 (2006), 321–327.
44. Hutcheson, J.D., Goettsch, C., Bertazzo, S., Maldonado, N., Ruiz, J.L., Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques. Nat. Mater. 15:3 (2016), 335–343.
45. Imoto, K., Hiro, T., Fujii, T., Murashige, A., Fukumoto, Y., Hashimoto, G., Okamura, T., Yamada, J., Mori, K., Matsuzaki, M., Longitudinal structural determinants of atherosclerotic plaque vulnerability: a computational analysis of stress distribution using vessel models and three-dimensional intravascular ultrasound imaging. J. Am. Coll. Cardiol. 46:8 (2005), 1507–1515.
46. Jain, R.K., Molecular regulation of vessel maturation. Nat. Med. 9:6 (2003), 685–693.
47. Jain, R.K., Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer Cell 26:5 (2014), 605–622.
48. Jaipersad, A.S., Lip, G.Y., Silverman, S., Shantsila, E., The role of monocytes in angiogenesis and atherosclerosis. J. Am. Coll. Cardiol. 63:1 (2014), 1–11.
49. Jeney, V., Balla, G., Balla, J., Red blood cell, hemoglobin and heme in the progression of atherosclerosis. Front Physiol., 5, 2014, 379.
50. Khurana, R., Simons, M., Martin, J.F., Zachary, I.C., Role of angiogenesis in cardiovascular disease. A Crit. Apprais. 112:12 (2005), 1813–1824.
51. Kojima, Y., Volkmer, J.P., McKenna, K., Civelek, M., Lusis, A.J., Miller, C.L., Direnzo, D., Nanda, V., Ye, J., Connolly, A.J., Schadt, E.E., Quertermous, T., Betancur, P., Maegdefessel, L., Matic, L.P., Hedin, U., Weissman, I.L., Leeper, N.J., CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature 536:7614 (2016), 86–90.
52. Kolodgie, F.D., Burke, A.P., Nakazawa, G., Cheng, Q., Xu, X., Virmani, R., Free cholesterol in atherosclerotic plaques: where does it come from?. Curr. Opin. Lipidol. 18:5 (2007), 500–507.
53. Kolodgie, F.D., Gold, H.K., Burke, A.P., Fowler, D.R., Kruth, H.S., Weber, D.K., Farb, A., Guerrero, L.J., Hayase, M., Kutys, R., Narula, J., Finn, A.V., Virmani, R., Intraplaque hemorrhage and progression of coronary atheroma. N. Engl. J. Med. 349:24 (2003), 2316–2325.
54. Lando, D., Peet, D.J., Gorman, J.J., Whelan, D.A., Whitelaw, M.L., Bruick, R.K., FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16:12 (2002), 1466–1471.
55. Lando, D., Peet, D.J., Whelan, D.A., Gorman, J.J., Whitelaw, M.L., Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295:5556 (2002), 858–861.
56. Langheinrich, A.C., Sedding, D.G., Kampschulte, M., Moritz, R., Wilhelm, J., Haberbosch, W.G., Ritman, E.L., Bohle, R.M., 3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE(-/-)/LDL(-/-) double knockout mice. Atherosclerosis 202:1 (2009), 103–110.
57. Lappalainen, H., Laine, P., Pentikainen, M.O., Sajantila, A., Kovanen, P.T., Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator. Arterioscler. Thromb. Vasc. Biol. 24:10 (2004), 1880–1885.
58. Lardenoye, J.H., de Vries, M.R., Löwik, C.W., Xu, Q., Dhore, C.R., Cleutjens, J.P., van Hinsbergh, V.W., van Bockel, J.H., Quax, P.H., Accelerated atherosclerosis and calcification in vein grafts: a study in APOE*3 Leiden transgenic mice. Circ. Res 91:7 (2002), 577–584.
59. Leclercq, A., Houard, X., Philippe, M., Ollivier, V., Sebbag, U., Meilhac, O., Michel, J.B., Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J. Leukoc. Biol. 82:6 (2007), 1420–1429.
60. Lee, J.W., Bae, S.H., Jeong, J.W., Kim, S.H., Kim, K.W., Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp. Mol. Med. 36:1 (2004), 1–12.
61. Li, J., Hou, B., Tumova, S., Muraki, K., Bruns, A., Ludlow, M.J., Sedo, A., Hyman, A.J., McKeown, L., Young, R.S., Yuldasheva, N.Y., Majeed, Y., Wilson, L.A., Rode, B., Bailey, M.A., Kim, H.R., Fu, Z., Carter, D.A., Bilton, J., Imrie, H., Ajuh, P., Dear, T.N., Cubbon, R.M., Kearney, M.T., Prasad, K.R., Evans, P.C., Ainscough, J.F., Beech, D.J., Piezo1 integration of vascular architecture with physiological force. Nature 515:7526 (2014), 279–282.
62. Lijkwan, M.A., Hellingman, A.A., Bos, E.J., van der Bogt, K.E., Huang, M., Kooreman, N.G., de Vries, M.R., Peters, H.A., Robbins, R.C., Hamming, J.F., Quax, P.H., Wu, J.C., Short hairpin RNA gene silencing of prolyl hydroxylase-2 with a minicircle vector improves neovascularization of hindlimb ischemia. Hum. Gene Ther. 25:1 (2014), 41–49.
63. Magnoni, M., Ammirati, E., Camici, P.G., Non-invasive molecular imaging of vulnerable atherosclerotic plaques. J. Cardiol. 65:4 (2015), 261–269.
64. Marsch, E., Demandt, J.A., Theelen, T.L., Tullemans, B.M., Wouters, K., Boon, M.R., van Dijk, T.H., Gijbels, M.J., Dubois, L.J., Meex, S.J., Mazzone, M., Hung, G., Fisher, E.A., Biessen, E.A., Daemen, M.J., Rensen, P.C., Carmeliet, P., Groen, A.K., Sluimer, J.C., Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia. Eur. Heart J. 37:39 (2016), 2993–2997.
65. Marsch, E., Sluimer, J.C., Daemen, M.J., Hypoxia in atherosclerosis and inflammation. Curr. Opin. Lipidol. 24:5 (2013), 393–400.
66. Martin, J.D., Fukumura, D., Duda, D.G., Boucher, Y., Jain, R.K., “Reengineering the tumor microenvironment to alleviate hypoxia and overcome cancer heterogeneity. Cold Spring Harb. Perspect. Med., 6(12), 2016.
67. Matter, C.M., Schuler, P.K., Alessi, P., Meier, P., Ricci, R., Zhang, D., Halin, C., Castellani, P., Zardi, L., Hofer, C.K., Montani, M., Neri, D., Lüscher, T.F., Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin. Circ. Res. 95:12 (2004), 1225–1233.
68. Melder, R.J., Yuan, J., Munn, L.L., Jain, R.K., Erythrocytes enhance lymphocyte rolling and arrest in vivo. Microvasc. Res. 59:2 (2000), 316–322.
69. Menden, H., Welak, S., Cossette, S., Ramchandran, R., Sampath, V., Lipopolysaccharide (LPS)-mediated angiopoietin-2-dependent autocrine angiogenesis is regulated by NADPH oxidase 2 (Nox2) in human pulmonary microvascular endothelial cells. J. Biol. Chem. 290:9 (2015), 5449–5461.
70. Michel, J.B., Martin-Ventura, J.L., Nicoletti, A., Ho-Tin-Noe, B., Pathology of human plaque vulnerability: mechanisms and consequences of intraplaque haemorrhages. Atherosclerosis 234:2 (2014), 311–319.
71. Michel, J.B., Virmani, R., Arbustini, E., Pasterkamp, G., Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur. Heart J. 32:16 (2011), 1977–1985 (1985a, 1985b, 1985c).
72. Moulton, K.S., Heller, E., Konerding, M.A., Flynn, E., Palinski, W., Folkman, J., Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99:13 (1999), 1726–1732.
73. Nagy, E., Eaton, J.W., Jeney, V., Soares, M.P., Varga, Z., Galajda, Z., Szentmiklósi, J., Méhes, G., Csonka, T., Smith, A., Vercellotti, G.M., Balla, G., Balla, J., Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 30:7 (2010), 1347–1353.
74. Nagy, J.A., Chang, S.H., Shih, S.C., Dvorak, A.M., Dvorak, H.F., Heterogeneity of the tumor vasculature. Semin Thromb. Hemost. 36:3 (2010), 321–331.
75. Nagy, J.A., Dvorak, A.M., Dvorak, H.F., Vascular hyperpermeability, angiogenesis, and stroma generation. Cold Spring Harb. Perspect. Med., 2(2), 2012, a006544.
76. Nakano, D., Hayashi, T., Tazawa, N., Yamashita, C., Inamoto, S., Okuda, N., Mori, T., Sohmiya, K., Kitaura, Y., Okada, Y., Matsumura, Y., Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice. Hypertens. Res. 28:10 (2005), 837–845.
77. O'Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J.R., Olsen, B.R., Folkman, J., Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:2 (1997), 277–285.
78. Oliver, K.M., Garvey, J.F., Ng, C.T., Veale, D.J., Fearon, U., Cummins, E.P., Taylor, C.T., Hypoxia activates NF-kappaB-dependent gene expression through the canonical signaling pathway. Antioxid. Redox Signal 11:9 (2009), 2057–2064.
79. Ozaki, M., Kawashima, S., Yamashita, T., Hirase, T., Namiki, M., Inoue, N., Hirata, K., Yasui, H., Sakurai, H., Yoshida, Y., Masada, M., Yokoyama, M., Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J. Clin. Investig. 110:3 (2002), 331–340.
80. Palazon, A., Goldrath, A.W., Nizet, V., Johnson, R.S., HIF transcription factors, inflammation, and immunity. Immunity 41:4 (2014), 518–528.
81. Perez-Medina, C., Binderup, T., Lobatto, M.E., Tang, J., Calcagno, C., Giesen, L., Wessel, C.H., Witjes, J., Ishino, S., Baxter, S., Zhao, Y., Ramachandran, S., Eldib, M., Sanchez-Gaytan, B.L., Robson, P.M., Bini, J., Granada, J.F., Fish, K.M., Stroes, E.S., Duivenvoorden, R., Tsimikas, S., Lewis, J.S., Reiner, T., Fuster, V., Kjaer, A., Fisher, E.A., Fayad, Z.A., Mulder, W.J., In vivo PET imaging of HDL in multiple atherosclerosis models. JACC Cardiovasc Imaging 9:8 (2016), 950–961.
82. Pircher, A., Treps, L., Bodrug, N., Carmeliet, P., Endothelial cell metabolism: a novel player in atherosclerosis? Basic principles and therapeutic opportunities. Atherosclerosis 253 (2016), 247–257.
83. Post, S., Peeters, W., Busser, E., Lamers, D., Sluijter, J.P., Goumans, M.J., de Weger, R.A., Moll, F.L., Doevendans, P.A., Pasterkamp, G., Vink, A., Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density. J. Vasc. Res. 45:3 (2008), 244–250.
84. Pouyssegur, J., Dayan, F., Mazure, N.M., Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441:7092 (2006), 437–443.
85. Pugh, C.W., Ratcliffe, P.J., Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9:6 (2003), 677–684.
86. Qiu, W., Kass, D.A., Hu, Q., Ziegelstein, R.C., Determinants of shear stress-stimulated endothelial nitric oxide production assessed in real-time by 4,5-diaminofluorescein fluorescence. Biochem. Biophys. Res. Commun. 286:2 (2001), 328–335.
87. Rademakers, T., Douma, K., Hackeng, T.M., Post, M.J., Sluimer, J.C., Daemen, M.J., Biessen, E.A., Heeneman, S., van Zandvoort, M.A., Plaque-associated vasa vasorum in aged apolipoprotein E-deficient mice exhibit proatherogenic functional features in vivo. Arterioscler. Thromb. Vasc. Biol. 33:2 (2013), 249–256.
88. Ramkhelawon, B., Yang, Y., van Gils, J.M., Hewing, B., Rayner, K.J., Parathath, S., Guo, L., Oldebeken, S., Feig, J.L., Fisher, E.A., Moore, K.J., Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques: a mechanism for macrophage retention and survival. Arterioscler. Thromb. Vasc. Biol. 33:6 (2013), 1180–1188.
89. Roiniotis, J., Dinh, H., Masendycz, P., Turner, A., Elsegood, C.L., Scholz, G.M., Hamilton, J.A., Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J. Immunol. 182:12 (2009), 7974–7981.
90. Ruiz, J.L., Hutcheson, J.D., Aikawa, E., Cardiovascular calcification: current controversies and novel concepts. Cardiovasc. Pathol. 24:4 (2015), 207–212.
91. Schoors, S., Bock, K. De, Cantelmo, Anna R., Georgiadou, M., Ghesquière, B., Cauwenberghs, S., Kuchnio, A., Wong, Brian W., Quaegebeur, A., Goveia, J., Bifari, F., Wang, X., Blanco, R., Tembuyser, B., Cornelissen, I., Bouché, A., Vinckier, S., Diaz-Moralli, S., Gerhardt, H., Telang, S., Cascante, M., Chesney, J., Dewerchin, M., Carmeliet, P., Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis. Cell Metab. 19:1 (2014), 37–48.
92. Schrijvers, D.M., De Meyer, G.R., Kockx, M.M., Herman, A.G., Martinet, W., Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25:6 (2005), 1256–1261.
93. Seghers, L., de Vries, M.R., Pardali, E., Hoefer, I.E., Hierck, B.P., ten Dijke, P., Goumans, M.J., Quax, P.H., Shear induced collateral artery growth modulated by endoglin but not by ALK1. J. Cell Mol. Med. 16:10 (2012), 2440–2450.
94. Semenza, G.L., Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3:10 (2003), 721–732.
95. Sewduth, R., Santoro, M.M., “Decoding” angiogenesis: new facets controlling endothelial cell behavior. Front. Physiol., 7, 2016, 306.
96. Sluimer, J.C., Daemen, M.J., Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J. Pathol. 218:1 (2009), 7–29.
97. Sluimer, J.C., Gasc, J.M., van Wanroij, J.L., Kisters, N., Groeneweg, M., Sollewijn Gelpke, M.D., Cleutjens, J.P., van den Akker, L.H., Corvol, P., Wouters, B.G., Daemen, M.J., Bijnens, A.P., Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J. Am. Coll. Cardiol. 51:13 (2008), 1258–1265.
98. Sluimer, J.C., Kolodgie, F.D., Bijnens, A.P., Maxfield, K., Pacheco, E., Kutys, B., Duimel, H., Frederik, P.M., van Hinsbergh, V.W., Virmani, R., Daemen, M.J., Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J. Am. Coll. Cardiol. 53:17 (2009), 1517–1527.
99. Tabas, I., Bornfeldt, K.E., Macrophage phenotype and function in different stages of atherosclerosis. Circ. Res. 118:4 (2016), 653–667.
100. Taqueti, V.R., Di Carli, M.F., Jerosch-Herold, M., Sukhova, G.K., Murthy, V.L., Folco, E.J., Kwong, R.Y., Ozaki, C.K., Belkin, M., Nahrendorf, M., Weissleder, R., Libby, P., Increased microvascularization and vessel permeability associate with active inflammation in human atheromata. Circ. Cardiovasc. Imaging 7:6 (2014), 920–929.
101. Theelen, T.L., Lappalainen, J.P., Sluimer, J.C., Gurzeler, E., Cleutjens, J.P., Gijbels, M.J., Biessen, E.A., Daemen, M.J., Alitalo, K., Ylä-Herttuala, S., Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice. Atherosclerosis 241:2 (2015), 297–304.
102. Tian, H., McKnight, S.L., Russell, D.W., Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11:1 (1997), 72–82.
103. Tsujita, K., Kaikita, K., Araki, S., Yamada, T., Nagamatsu, S., Yamanaga, K., Sakamoto, K., Kojima, S., Hokimoto, S., Ogawa, H., In Vivo optical coherence tomography visualization of intraplaque neovascularization at the site of coronary vasospasm: a case report. BMC Cardiovasc Disord., 16(1), 2016, 235.
104. Tziakas, D.N., Chalikias, G.K., Stakos, D., Tentes, I.K., Papazoglou, D., Grapsa, A., Gioka, G., Kaski, J.C., Boudoulas, H., Independent and additive predictive value of total cholesterol content of erythrocyte membranes with regard to coronary artery disease clinical presentation. Int. J. Cardiol. 150:1 (2011), 22–27 (Jul 1).
105. Van der Donckt, C., Van Herck, J.L., Schrijvers, D.M., Vanhoutte, G., Verhoye, M., Blockx, I., Van Der Linden, A., Bauters, D., Lijnen, H.R., Sluimer, J.C., Roth, L., Van Hove, C.E., Fransen, P., Knaapen, M.W., Hervent, A.S., De Keulenaer, G.W., Bult, H., Martinet, W., Herman, A.G., De Meyer, G.R., Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death. Eur. Heart J. 36:17 (2015), 1049–1058.
106. Van der Veken, B., De Meyer, G.R., Martinet, W., Intraplaque neovascularization as a novel therapeutic target in advanced atherosclerosis. Expert Opin. Ther. Targets, 2016, 1–11.
107. Van Herck, J.L., De Meyer, G.R., Martinet, W., Van Hove, C.E., Foubert, K., Theunis, M.H., Apers, S., Bult, H., Vrints, C.J., Herman, A.G., Impaired fibrillin-1 function promotes features of plaque instability in apolipoprotein E-deficient mice. Circulation 120:24 (2009), 2478–2487.
108. van Hinsbergh, V.W.M., Eringa, E.C., Daemen, M., Neovascularization of the atherosclerotic plaque: interplay between atherosclerotic lesion, adventitia-derived microvessels and perivascular fat. Curr. Opin. Lipidol. 26:5 (2015), 405–411.
109. van Uden, P., Kenneth, N.S., Rocha, S., Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem. J. 412:3 (2008), 477–484.
110. Wang, H., Gardecki, J.A., Ughi, G.J., Jacques, P.V., Hamidi, E., Tearney, G.J., Ex vivo catheter-based imaging of coronary atherosclerosis using multimodality OCT and NIRAF excited at 633 nm. Biomed. Opt. Express 6:4 (2015), 1363–1375.
111. Wang, Y., Zhou, Y., He, L., Hong, K., Su, H., Wu, Y., Wu, Q., Han, M., Cheng, X., Gene delivery of soluble vascular endothelial growth factor receptor-1 (sFlt-1) inhibits intra-plaque angiogenesis and suppresses development of atherosclerotic plaque. Clin. Exp. Med. 11:2 (2011), 113–121.
112. Wezel, A., de Vries, M.R., Maassen, J.M., Kip, P., Peters, E.A., Karper, J.C., Kuiper, J., Bot, I., Quax, P.H., Deficiency of the TLR4 analogue RP105 aggravates vein graft disease by inducing a pro-inflammatory response. Sci. Rep., 6, 2016, 24248.
113. Wiesener, M.S., Turley, H., Allen, W.E., Willam, C., Eckardt, K.U., Talks, K.L., Wood, S.M., Gatter, K.C., Harris, A.L., Pugh, C.W., Ratcliffe, P.J., Maxwell, P.H., Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 92:7 (1998), 2260–2268.
114. Willems, S., Vink, A., Bot, I., Quax, P.H.A., de Borst, G.J., de Vries, J.-P.P.M., van de Weg, S.M., Moll, F.L., Kuiper, J., Kovanen, P.T., de Kleijn, D.P.V., Hoefer, I.E., Pasterkamp, G., Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events. Eur. Heart J. 34:48 (2013), 3699–3706.
115. Winnik, S., Lohmann, C., Siciliani, G., von Lukowicz, T., Kuschnerus, K., Kraenkel, N., Brokopp, C.E., Enseleit, F., Michels, S., Ruschitzka, F., Luscher, T.F., Matter, C.M., Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis - implications for cardiovascular safety. Int. J. Cardiol. 168:3 (2013), 2453–2461.
116. Wong, C., Bezhaeva, T., Rothuizen, T.C., Metselaar, J.M., de Vries, M.R., Verbeek, F.P., Vahrmeijer, A.L., Wezel, A., van Zonneveld, A.J., Rabelink, T.J., Quax, P.H., Rotmans, J.I., Liposomal prednisolone inhibits vascular inflammation and enhances venous outward remodeling in a murine arteriovenous fistula model. Sci. Rep., 6, 2016, 30439.
117. Wong, C.Y., de Vries, M.R., Wang, Y., van der Vorst, J.R., Vahrmeijer, A.L., van Zonneveld, A.J., Roy-Chaudhury, P., Rabelink, T.J., Quax, P.H., Rotmans, J.I., Vascular remodeling and intimal hyperplasia in a novel murine model of arteriovenous fistula failure. J. Vasc. Surg. 59:1 (2014), 192–201 (e191).
118. Xu, J.Y., Lu, X.T., Shi, G.P., Vasa Vasorum in atherosclerosis and clinical significance. Int. J. Mol. Sci. 16:5 (2015), 11574–11608.
119. Xu, X., Mao, W., Chai, Y., Dai, J., Chen, Q., Wang, L., Zhuang, Q., Pan, Y., Chen, M., Ni, G., Huang, Z., Angiogenesis Inhibitor, endostar, prevents vasa vasorum neovascularization in a swine atherosclerosis model. J. Atheroscler. Thromb. 22:10 (2015), 1100–1112.
120. Yahagi, K., Kolodgie, F.D., Otsuka, F., Finn, A.V., Davis, H.R., Joner, M., Virmani, R., Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat. Rev. Cardiol. 13:2 (2016), 79–98.